Abbott Rapid Dx North America LLC D1200 - … | USA MedPremium
Cancer Screening Test Kit NMP22® Bladderchek® Bladder Cancer 24 Tests CLIA Waived
USAMP#70930805SKU: D1200NMP22® Bladderchek®
Product Spotlight
A Rapid Test for the Qualitative Detection of Alere NMP22 Nuclear Matrix Protein in human urine
The Alere NMP22® BladderChek® Test is an in vitro immunoassay intended for the qualitative detection of the nuclear mitotic apparatus protein (NuMA), which is an abundant component of the nuclear matrix proteins, in urine of persons with risk factors or symptoms of bladder cancer or with a history of bladder cancer
This test is indicated for professional use and prescription home use as an aid in diagnosing and monitoring bladder cancer patients, in conjunction with standard diagnostic procedures
Each device incorporates colloidal gold particles conjugated to the reporter antibody and a capture monoclonal antibody, immobilized on a membrane; the procedural Control zone contains an immobilized goat anti-mouse IgG-specific antibody
